Clinical Trial Update: Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BOL-303242-X versus vehicle for inflammation after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Inflammation

Drugs mentioned

• BOL-303242-X

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract, Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2020-09-03